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ABSTRACT   
Background:  Diabetes is a prevalent chronic illness, affecting up to 23.6 million people 
in the United States. The association of diabetes and cognitive dysfunction is well 
recognized, and many have suggested memory to be among the cognitive functions most 
affected. The proposal of chronic hyperglycemia having a negative effect on cognition 
independent of other risk factors has yet to be determined. 
Methods:  An extensive literature search was performed using Medline, CINAHL, and 
Web of Science databases. Titles and abstracts were screened for relevancy and discarded 
if clearly not eligible. The full text of potential studies was reviewed for at least one 
objective measurement of memory in type II diabetic participants with correlation to level 
of control as measured by HbA1c. The references of selected studies and review articles 
were evaluated for additional publications. 
Results:  The majority of reviewed studies did not find a significant association between 
HbA1c and performance on tests of verbal and visual memory. Extensive variation in 
study design was found including control over confounding factors and selection of 
cognitive testing. 
Conclusion:  Studies on the relationship between level of control of diabetes and 
cognition are both limited and confounded by lack of control of comorbitities within 
study designs. Further research within carefully designed longitudinal studies is 
necessary to better understand any existing relationship between level of glucose control 
and cognition, and may spotlight the need for specialized education and support 
regarding disease self-management for people with type II diabetes. 
Keywords:  glycosylated hemoglobin, HbA1c, diabetes mellitus, type II diabetes, 
cognition, cognitive, chronic, hyperglycemia 
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The Relationship of Blood Glucose Control Level and Memory in Type 
II Diabetic Patients 
 
BACKGROUND 
Diabetes is a prevalent, progressive, and often disabling disease; affecting up to 
23.6 million people in the United States.1,2 The number of Americans with diagnosed 
diabetes mellitus (types I and II) is projected to increase 165%, from 11 million people in 
the year 2000 to 29 million in 2050.3 Numerous literature reviews reviewing dozens of 
published studies have found considerable support for an association of type II diabetes 
and cognitive dysfunction, specifically that diabetics seem to show the most impairment 
in the cognitive domain memory.4,5 However, because the lack of control over 
confounding factors in most if not all of the currently published studies, it is less clear on 
which and to what extent the comorbidities associated with this disease may be 
attributing to these deficits. Determining the independent role of chronic high blood 
glucose on brain functioning will provide more insight to the pathophysiology of the 
disease, potentially modify guidelines for disease management, and give direction for 
further research in this field. Particularly, if hyperglycemia has a negative impact on 
cognition, this will have significant implications for the ability of type II diabetic patients 
to effectively self-manage their disease. The primary purpose of this study is to determine 
whether poor control of diabetes is a risk factor for memory impairment in type II 
diabetic patients independent of other conditions commonly associated with this disease 
including depression, hyperlipidemia, hypertension, and vascular disease. Secondly, an 
attempt to describe the ideal study on the relationship of HbA1c and cognition was made 
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to best contribute to our understanding of this disease. The review was also designed to 
easily incorporate the evaluation of other domains of cognition within the selected 
studies. 
 
METHODS 
An extensive literature search using Medline, CINAHL, and Web of Science 
databases was performed using the following search terms: glycosylated hemoglobin, 
HbA1c, diabetes mellitus, type II diabetes, cognition, cognitive, chronic, and 
hyperglycemia. The references of selected studies and review articles were evaluated for 
additional publications. Titles and abstracts were screened for relevancy and discarded if 
clearly not eligible. The full text of the remaining references were reviewed and selected 
for inclusion based on the following inclusion and exclusion criteria. Studies included in 
this review were required to involve a population of participants with adult type II 
diabetes, use HbA1c as an indicator for diabetes level of control, at least one objective 
test of cognition, and have the relationship of glycemic control and cognition as a 
primary focus. Only studies published in English were selected. Exclusion criteria 
included pediatric populations, cognitive testing performed under and correlated with 
acute hyperglycemic episodes, no distinctly examined type II diabetic population, or 
studies published prior to 2000. The date for exclusion was chosen due to the abundance 
of relevant articles and because of the advances in diabetes understanding and treatment 
in the last decade, to review the latest research with potentially higher quality studies. 
Sixteen studies were found and further analyzed for testing of the cognitive domain 
memory.  
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Measures of Cognitive Function 
 Forty-three different cognitive tests were administered among the sixteen studies 
meeting the inclusion and exclusion criteria. Due to the lack of congruency between 
studies on the type of cognition sensitive to each test, and consistency between similar 
review articles, the classification of cognitive abilities according to Lezak described in 
“Neuropsychological Assessment” was used.6 Although many tests call upon several 
major cognitive functional activities making the assignment to a single cognitive domain 
arbitrary, eight broad categories of cognition were found to be assessed in these studies: 
overall mental status; verbal function and language skills; construction; motor 
performance; attention, concentration and tracking; concept formation and reasoning; 
perception; and memory.6 Table 1 illustrates the categorization and study references 
using each cognitive test. If a particular test was not found under Lezak’s classifications, 
the test description was evaluated and correlated with a similar classified test and placed 
under the respective category. If a particular test was insufficiently described, without a 
locatable reference published in English using the above databases, and not described by 
Lezak, the test was excluded from review (see Table 1). Studies assessing memory with 
no mention of results7 or explicit memory result as a part of an overall cognition test,8-16 
were excluded. Tests classified as working memory were not included in this review due 
to its categorization as tracking, and as so are classified under the attention, 
concentration, and tracking category. If a study provided only an overall statistical score 
for a group of memory tests including a test not assigned as memory by this study’s 
classification method17-19 or did not correlate memory with HbA1c,14 the data could not 
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be analyzed for inclusion in this review. Six studies including seven memory tests were 
found by the described classification method and were included in this review.8,11,16,18,20,21 
Data was then abstracted from the articles and analyzed.  
   
Data Abstraction 
 The selected studies can be found listed with population characteristics in Table 
2. Information recorded from each study included diabetic population characteristics 
(number of participants, mean age, percent male, duration of diabetes, mean HbA1c), and 
study type. 
 
Validity Assessment 
Validity was assessed using a subjective quality scale based on a number of 
individual quality components and scored numerically to provide a quantitative estimate 
of overall study quality. This was assembled using quality criteria presented in the Centre 
for Reviews and Dissemination Report22 and the Data Collection Instrument and 
Procedure for Systematic Reviews in the Guide to Community Preventive Services23 
tailored to fit this study.22,23 The individual quality components include specific aspects 
of study methodology that have a potential relation to bias.22 Because type II diabetes is 
associated with numerous comorbidities that may independently contribute to cognitive 
decline, each potentially confounding variable was assigned one point to provide greater 
weight in determining validity.  A total score for each study was determined by assigning 
each quality component one point for “Yes” and zero points for “No” and calculating a 
total sum (Table 3). The validity of methods diagnosing or scoring confounding variables 
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and cognitive tests themselves was not assessed for this review as this reaches beyond the 
scope of this article. 
 
RESULTS 
Studies Reporting a Negative Correlation of HbA1c and Memory 
 Of the six studies reviewed, two reported a negative correlation with memory 
deficits and HbA1c in participants with type II diabetes (see Table 4). Cukierman-Yaffe 
et al8 performed a large cross-sectional study of participants in the ongoing Action to 
Control Cardiovascular Risk in Diabetes- Memory in Diabetes (ACCORD-MIND) trial, a 
substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
Using baseline data from the MIND study, the relationship between the degree of 
hyperglycemia and cognitive status was assessed in 2,977 diabetic men and women. A 
statistically significant age-adjusted association was found between HbA1c level and the 
verbal memory test score, specifically a 0.11 point lower score (-0.02 to -0.19, P = 
0.0142) per 1% rise in HbA1c.8 
 A study by Umegaki et al11 evaluated 77 patients with relatively well-controlled 
type II diabetes for an association of HbA1c, hyperinsulinemia, and ischemic brain 
changes with diabetes-related cognitive dysfunction. HbA1c was found to be associated 
with decreased performance on the memory test administered (correlation coefficient -
0.194, P = < 0.05).11 
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Studies Reporting no Correlation of HbA1c and Memory 
 The majority of the remaining studies evaluating memory did not find significant 
associations between HbA1c and memory function. Van Harten et al16 described the 
neuropsychological profile of 92 participants with diabetes and 44 control subjects 
without diabetes, and studied the correlations of cognitive impairment and brain lesions 
on MRI and influence of relevant disease variables of diabetes including HbA1c on 
cognition. Although significant differences in cognition between groups were found and 
overall cognition was associated with HbA1c, the results of memory determined by 
scores of two verbal memory tests was similar between groups and not independently 
associated with HbA1c.16 
 Ryan et al18 evaluated 50 middle aged adults between 34-65 years old with 
diabetes and 50 demographically similar control subjects without diabetes to determine 
the extent to which demographic and biomedical variables contributed to performance on 
each of four cognitive domains. Performance on the domain memory, consisting of one 
memory test, was not found to be influenced by HbA1c.18 A similarly small study by 
Cosway et al20 of 38 uncomplicated type II diabetic and 38 non-diabetic control 
participants 40-75 years old aimed to compare cognitive function and information 
processing of diabetic persons with non-diabetic persons and determine if factors within 
the group of diabetics correlated with cognitive function. HbA1c was determined by 
averaging up to three levels obtained at prior clinic visits, and not drawn at the time of 
cognitive testing. The performance on two memory tests in this study also displayed no 
correlation with HbA1c.20 
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 Finally, Saczynski et al21 used data from the Age, Gene/Environment 
Susceptibility-Reykjavik Study examining the association of specific measures of 
cognitive function to four categories of glycemic status: normoglycemic, impaired fasting 
glucose, undiagnosed diabetes, and diagnosed diabetes. The relation of cognitive 
performance to HbA1c levels, duration of clinically recognized type II diabetes, and 
medication use was also examined. Of the 1,917 subjects, 163 had diagnosed type II 
diabetes mellitus and 55 had undiagnosed type II diabetes mellitus, with both groups 
having relatively well controlled diabetes as measured by HbA1c. The level of control, 
however, was not related to performance in memory determined by the score of one 
memory test.21 
  
DISCUSSION 
 This literature review of cross-sectional studies draws a mixed conclusion in 
respect to the relationship between HbA1c and memory in people with type II diabetes. 
Four of six studies reviewed found no relationship between level of control of diabetes 
and performance on memory testing.16,18,20,21 However, one of the studies supporting a 
relationship was a large cross-sectional study using data from participants enrolled in a 
randomized control trial. The study had the highest rating of validity among the studies, 
and by far had both the most control over confounding factors and largest diabetic sample 
size of 2,977 participants (others ranged from 38-163 participants).8 The other study 
reporting an HbA1c and memory correlation did so despite a relatively well controlled 
diabetic population (mean HbA1c 6.6 ± 0.8), but had a low validity score due to lack of 
controlling for many confounding factors.11 Both studies exhibited a relatively long 
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duration of diabetes and high level of education in their population sample. Interestingly, 
these two studies supporting a relationship between HbA1c and memory performance 
were the only studies in the review stating that the relationship of HbA1c and cognitive 
function was their primary focus of research.  
  
Study Limitations  
Of more significant importance than the actual results of the studies is the issue of 
inconsistency in the research of this topic. A number of factors may account for the 
difference in findings among studies of HbA1c and cognition. The study designs are 
considerably different, making it extremely difficult to make any useful comparisons 
between them. The most common discrepancies are discussed below, and therefore assist 
in defining the ideal study on the effect of level of control of diabetes on cognition. 
 
Sample selection 
 One of the most important factors relevant to the study of HbA1c and cognition is 
the use of strict exclusion criteria and statistical adjustment regarding important 
confounding variables. Type II diabetes is a complex disease process as it is associated 
with numerous multisystem complications and other significant disorders and conditions 
that may each contribute independently to cognitive dysfunction. These confounding 
variables are numerous and include hypertension, hyperlipidemia, cerebrovascular 
disease, cardiovascular disease, HPA (hypothalamic-pituitary-adrenal) axis 
abnormalities, metabolic syndrome, severe hypoglycemic episodes, hyperinsulinemia, 
and depression. Other confounding variables include age-associated cognitive decline, 
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gender, education level, previous occupation, functional disorders (visual, hearing and 
movement) that could interfere with testing, significant alcohol and drug use, smoking, 
exercise, psychiatric and neurological disorders including dementia and head injury, 
medications, and premorbid intelligence. An overview of how well each of the articles in 
this review accounted for these variables can be found in table 3. Only three of the six 
articles accounted for at least five confounding factors listed above; clearly not nearly 
enough to accurately propose causality of cognitive impairment in diabetic patients.8,16,18 
 As only some of the above factors are those that could be excluded from a sample 
selection, others such as education level, premorbid intelligence, gender, age, and 
duration of diabetes must be similar or adjusted for within the population sample. Only 
one study divided the population in terms of education level and gender and made 
respective adjustments in their statistical analysis.8 One study attempted to select and 
analyze participants in a similar point of their disease progression by creating a 
population of undiagnosed diabetic participants, defined as participants with no self-
report of diabetes, no use of diabetes medication, and a fasting blood glucose level 
greater than or equal to 7.0 mmol/L at the baseline examination. This study also 
categorized disease duration among diagnosed diabetic participants into four relatively 
equal-sized groups and compared them to the undiagnosed diabetes group; however no 
attempt was made to use this data to evaluate HbA1c and cognition within each group.21 
Intelligence was estimated in two of six studies.18,20 Evidently many of the studies 
considered important confounding variables however many of them were used for 
adjustment and comparison between groups and not specifically applied to the HbA1c 
and cognition analyses. 
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 There are several further aspects worth discussing regarding the sample 
population and study of cognition. Firstly, the potential bias introduced by selective 
recruitment may significantly affect the outcomes of the studies. Persons with more 
severe cognitive impairment would be less likely to participate in a study of cognition. 
This would underestimate the effect of level of control of diabetes on cognition if those 
participants were among those with very poorly-controlled diabetes. Secondly, the 
majority of studies based their results on very small populations, eliciting another 
possible reason for discrepancy among the study results. The findings from studies 
finding no association between level of control of diabetes and cognition may therefore 
result from a lack of appropriate numbers of participants to compare. Finally, the 
universe of selection of the diabetic participants may yield different results between 
studies. Two studies selected diabetic samples from the general population,8,21 two from 
diabetic clinics,11,20 one from a hospital internal medicine department,16 and one from a 
diabetes research subject registry.18 Participants selected from a diabetes clinic or internal 
medicine department are more likely to have additional and worse confounding 
conditions compared with those from the general diabetic population. If rigorous 
exclusion criteria or statistical adjustment were not used, participants selected from a 
sicker population would be more likely to show a decrease in cognition compared to a 
healthier sample, confounding any association found with HbA1c. If the majority of 
confounding variables are not accounted for, this would also pose a problem for 
comparing study results of participants from the general diabetic population to those from 
a diabetes clinic. 
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Study design and methodology 
 Several important details regarding the study of diabetes and cognition were 
inconsistently evaluated among the studies, effecting the interpretation of results. Only 
two of the studies explicitly stated a valid method of diagnosing diabetes by laboratory 
measurement, one only doing so for the undiagnosed diabetes sample.8,21 The remaining 
diagnosed diabetes samples were based on self-reported doctor’s diagnosis, use of 
diabetic medications, standardized questionnaires,21 or the method of diagnosis was not 
mentioned at all.11,16,18,20 Three of the four studies not stating the method of diagnosis 
were those whose sample was selected from an already established diabetic population, 
including the two diabetes clinics11,20 and diabetes research subject registry.18 Along the 
same lines, only five of the six studies provided a description of the method of obtaining 
HbA1c levels,8,11,18,20,21 with only one specifying the time period in which the laboratory 
and cognitive testing was performed.21 As time passes between HbA1c and cognitive 
testing, the more inaccurate the result of comparisons become; therefore the results of the 
studies not providing this piece of pertinent information have reduced validity. Lastly, of 
the four studies evaluating diabetic versus non-diabetic populations,16,18,20,21 and two 
studies evaluating diabetics only8,11 only one study specified that the examiner was blind 
to the diabetic status of the participants.16 
 Another important consideration of study design is to account for conditions that 
may interfere with cognitive testing including deficits of perception and aspects of acute 
blood glucose. An inability to sufficiently hear or see a portion of a cognitive test may 
markedly alter the performance measured for a particular domain and not test a person’s 
true cognitive functionality. Only one study ensured adequate visual perception by 
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applying a minimum visual acuity to participate, and one study simply stated there were 
no audio-visual deficits among the participants.11,20 Abnormalities in blood glucose 
during testing may also acutely affect the results of a particular cognitive test. Numerous 
studies have demonstrated the negative impact of hypoglycemia on cognitive 
dysfunction,24 however only three of six studies took this into account or ensured blood 
glucose to be ≥ 60 mg/dl prior to testing.8,18,20 Acute hyperglycemia has also been shown 
to impair cognitive function in type II diabetics in recent studies25,26 and was not 
addressed in any of the studies reviewed. This is a potentially significant detail in the 
study of the effect of HbA1c on cognition in that it may help distinguish whether or not 
any deficits in cognition associated with HbA1c are due to the chronic effects of 
hyperglycemia or acute hyperglycemia itself. There is also evidence to suggest the 
utilization of blood glucose rather than the actual glucose level may be associated with 
performance on cognitive tests among participants with type II diabetes.27 
 Additional features absent from the majority of studies are measures taken to 
ensure accuracy of the cognitive test scores and consistency between test givers. No study 
in this review repeated cognitive testing to obtain an average and more accurate score, 
which would help adjust for the possibility of unknown factors influencing performance 
at that particular time of testing. However, some of the studies attempted to provide 
consistency of scoring between participants by indicating that they administered the tests 
in the same order,11,18 used certified technicians to administer the tests,8 or calculated 
high inter-rater reliability.21  
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Selection and reporting results of cognitive testing 
 One of the most significant issues regarding consistency between studies is the 
selection of cognitive tests. There is currently no consensus regarding a standard 
neuropsychological test battery, leaving authors to choose among hundreds of tests to 
assess cognition. According to this review and other recent reviews of diabetes and 
cognitive function, memory and attention/concentration tests seem to be the most widely 
used.4,28,29 Forty-three different tests of cognitive function were used among the sixteen 
studies meeting the primary inclusion criteria in this review. The measure of cognitive 
function for each study ranged from a single neuropsychological test10,15 to a battery of 
14 tests,19 with an average of 5-6 tests administered among the studies. 
The method of analyzing the studies in this review using an independent 
classification system for tests was chosen for several reasons. A number of studies were 
found to show discrepancies in classifying cognitive tests. For example, both Manschot et 
al17 and Ruis et al19 assessed memory based on several tests including the forward and 
backward Digit Span.17,19 Saczynski et al21 also used the forward and backward Digit 
Span test, except classified as a test of executive function.21 Another reason for choosing 
to compare results of cognitive domains to HbA1c is that the alternative, individual test 
performance could not effectively be compared among the studies without omitting a 
large proportion of relevant articles. Evaluating over forty cognitive tests with no two 
studies using the same tests would create far too many variables to effectively assess 
HbA1c and cognition relation in one literature review. Also, if one were to include only 
the most common tests administered, potentially relevant information attained by other 
studies would be excluded. Finally, many studies do not analyze the relationship between 
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individual test scores and HbA1c. They alternatively evaluate the relationship of HbA1c 
and result of performance in a particular domain, derived from tests they defined as 
testing that domain.7,17-19,21,30 Excluding these studies from review would contribute to 
the loss of further potentially relevant data.  
 
Implications for Diabetes Self-Management 
After further and more comprehensive studies are done, data continuing to 
support a negative correlation of chronic hyperglycemia on cognition would promote 
interest on whether or not patients fitting within this category are able to effectively 
manage their own disease. It is important to consider the possibility that patients with 
relatively high HbA1c levels may be less well-controlled due to established cognitive 
impairment. Studies examining the association between impaired cognition and diabetes 
self-care have shown that diabetic subjects with lower cognitive test scores were less 
likely to be involved in self-care.31,32 These findings imply that whether due to age-
associated or other causes of cognitive decline, people with type II diabetes may require 
additional teaching and support in order to manage this condition. In fact, there is 
evidence to support patients with type II diabetes and impaired cognitive function benefit 
from specialized structured treatment and teaching programs by demonstrating better 
diabetes self-management compared to those in standard diabetes treatment and teaching 
programs.33 
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CONCLUSION 
 Over the last decade, a number of studies have evaluated the association of 
HbA1c levels and memory in people with type II diabetes, with the majority indicating 
no significant relationship between them. However, the wide variation in methodology, 
selection of cognitive tests, and control for confounding factors obscures both the 
conclusions of the individual studies and any meaningful comparisons between them. 
Studies primarily evaluating this relationship are also few and far between. Further 
research within carefully designed longitudinal studies is necessary to better understand 
any existing relationship between level of glucose control and cognition, and may 
spotlight the need for specialized education and support regarding disease self-
management for people with type II diabetes. 
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TABLES  
Table 1   Classification of Tests by Categories of Cognition 
Memory Construction 
Test Reference Test Reference 
Rey Auditory Verbal Learning Test (immediate; 
delayed) 
8,16,17,19,20 Clock-in-a-box 13 
Location Learning Test (immediate; delayed) 17,19 Clock Drawing Test 7,13 
Rey-Osterreith Complex Figure Test (delayed) 19 Mosaic Test 30 
Logical Memory Test of the Rivermead Behavioral 
Memory Test (immediate; delayed) 
16 Copy Trial of the Rey-Osterreith Complex Figure Test 
17,19 
Word List subtest of Alzheimers Disease 
Assessment Scale 
11,14 Object Assembly Subtest of Wechsler Adult Intellegence Scale-Revised 
18 
Verbal Pairs of the Wechsler Memory Scale- 
Revised  
20    
Visual Pairs of the Wechsler Memory Scale- 
Revised 
20 Concept Formation and Reasoning 
Logical Memory Test of the Wechsler Memory 
Scale- Revised  
20 Raven Advanced Progressive Matrices 17,19,20 
Verbal Paired-Associate Learning Test (immediate; 
delayed)  
18 Brixton Spatial Anticipation Test 17,19 
Four Word Short Term Memory Test 18 Halstead Category Test 18 
California Verbal Learning Test 
(immediate;delayed) 
21 Problem Solving Test 7 
      
Attention, Concentration, and Tracking Verbal Function / Language Skills 
Digit Symbol Substitution Test  8,11,12,14,19,30 Category Fluncy 7,9,16,17,19 
Stroop Tests 8,16,19 Lexical Fluency Test 19 
Digit Span (forward; backward) 17,19,21 Token Test 19 
Corsi Block-Tapping Test 17,19 Controlled Oral Word Association Test 16 
Trail Making Test  9,16-19,30 Mehrfachwahl-Wortschatz Test 30 
Binary Choice Reaction Time of FEPSY 16 The Borkowski Verbal Fluency Test 20 
Symbol-Digit Paired Associate Learning Test 
(immediate; delayed) 
18    
Spatial Working Memory Test of the Cambridge 
Neuropsychological Test Battery 
21    
      
Overall Mental Status Perception 
Mini-Mental Status Examination or Teng Modified 
Mini-Mental Status Examination  
8-14 Tactual Performance Test 18 
Cambridge Cognitive Examination 16 Embedded Figures Test 18 
HIV Dementia Scale 16 Digit Vigilance Test 18 
Health and Retirement Study Cognitive Scale 15    
   Motor Performance 
  
 
Grooved Pegboard Test 16,18 
Other Tests: Figure Comparison Test [21 ] was excluded due to lack of sufficient written description, and referenced article could not be located. 
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Table 2   Diabetic population characteristics in selected studies 
Study Year Published 
Diabetic 
Subjects 
(n, % male) 
Age 
(years) 
Diabetes 
Duration 
(Years) 
Education 
(Years) 
HbA1c 
(%) Study Type 
 Validity Score 
(n/25) 
Cosway et al. 2001 38, 42% 57.7 ± 10.3 6.0 (3.0, 11.3) ♦ 11.2 ± 2.7 7.6 (6.6, 9.5) ♦ Cross-sectional 11 
Cukierman-Yaffe et 
al. 2009 2,997, 53% 62.5 ± 5.8 10.4 ± 7.3   ○ 8.3 ± 1.1 Cross-sectional 20 
Ryan et al. 2000 50, 30% 50.8 ± 7.7 8.1 ± 5.9 14.4 ± 3.1 10.2 ± 2.4 Cross-sectional 11 
Saczynski et al. 2008 
163, 66% † 75.6 ± 5.4 † 9 (3-19) † ■ 21.5 † ▲ 6.4 (6.0 -7.1) † ■ Cross-sectional 16 
55, 55% ‡ 75.9 ± 4.9 ‡ – ‡ 10.9 ‡ ▲ 6.2 (5.8-6.5) ‡ ■ 
Umegaki et al. 2008 77, 40% 74.5 ± 5.5 15.5 ± 8.9 9.4 ± 2.4 6.6 ± 0.8 Cross-sectional 8 
van Harten et al. 2007 92, 43% 73.2 ± 5.7 13.8 ± 10.8 4.0 (1.6) ● 7.7 ± 1.0 Cross-sectional 11 
Data are the mean ± standard deviation unless otherwise indicated. 
♦ Mean with 25th and 75th percentiles in parentheses 
■ Median with ranges in parentheses 
● Median with standard deviation in parentheses 
▲ Percent low education, study did not define 
† Diagnosed diabetes participants  
‡ Undiagnosed diabetes participants 
◊ Insulin-treated diabetes participants 
∆ Noninsulin treated diabetes participants 
○ Not a high school graduate- 13%, Just high school- 26%, Some college or technical school- 35%, 
College graduate or more- 27% 
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Table 3   Validity Scores 
 
Cosway    
et al. 
Cukierman-
Yaffe et al. 
Saczynski 
et al. 
Ryan            
et al. 
Umegaki  
et al. 
van 
Harten et 
al. 
Descriptions             
Was the study population well described? 1 1 1 1 1 1 
Sampling             
Did the authors specify the sampling frame or universe of selection for 
the study population? 
1 1 1 1 1 1 
Did the authors specify the sample was selected from the general 
diabetic population? 
0 1 1 1 0 0 
Did the authors specify the screening criteria for study eligibility? 1 1 1 1 1 1 
Are the groups assembled at a similar point in their disease progression? 
0 0 1* 0 0 0 
Measurement             
Did the authors specify a reliable and valid method of diagnosing 
diabetes? 
0 1 1* 0 0 0 
Did the authors specify a valid method of obtaining HbA1c measurement 
with blood drawn near the time of cognitive testing? 
0 1 1 0 0 0 
Did the authors specify that measures were taken to ensure the 
accuracy/consistency of the cognitive test scores obtained?  
0 1 1 1 1 0 
Did the authors specify that interviewers were blinded to diabetes status? 
0 0 0 0 0 1 
Data analysis             
Did the authors conduct appropriate analysis by conducting specified 
statistical testing? 
1 1 1 1 1 1 
Interpretation of Results             
Did at least 80% of enrolled participants complete the study? 1 1 1 1 1 1 
Was the study longitudinal? 0 0 0 0 0 0 
Did the authors ensure the lack of audio or visual defecits prior to 
cognitive testing? 
1 0 0 0 1 0 
Did the authors specify if blood glucose was measured prior to testing to 
exclude hypoglycemia? 
1 1 0 1 0 0 
Were important confounding variables methodologically controlled or 
statistically adjusted in regards to HbA1c? 
            
• Age 0 1 1 0 0 0 
• Sex 0 1 0 0 0 0 
• Neurological conditions, including head injuries 1 1 0 1 0 1 
• Psychiatric conditions 1 0 0 1 0 1 
• Depression/Depressive symptoms 0 1 1 0 0 0 
• Alcohol and/or Substance Abuse 1 1 0 1 0 1 
• Hypertension 0 1 1 0 0 0 
• Hyperlipidemia 0 1 0 0 0 0 
• Vascular complications, including myocardial infarction, unstable 
angina, nephropathy, retinopathy, cerebrovascular accidents, and/or 
transient ischemic attacks 
1 1 1 0 1 1 
• Premorbid intellegence/Education 0 1 1 0 0 0 
• Dementia 0 1 1 0 0 1 
              
Sum of Components 11 20 16 11 8 11 
             
*This study assessed both diagnosed and undiagnosed type II diabetic participants, the latter being similar in disease progression  stage and reliably diagnosed . 
 
Table 4   Results 
Study Memory 
  Verbal Visual 
Cosway et al. NS NS 
Cukierman-Yaffe et al. Sig * – 
Ryan et al. NS – 
Saczynski et al. NS – 
Umegaki et al. Sig * – 
van Harten et al. NS – 
NS = No significant correllation found between HbA1c and memory 
Sig = Significant correllation found between HbA1c and memory 
* P ≤ 0.05 
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